Next generation screening strategies for screening, triage and diagnosis can help clinicians find and treat disease, to stop cancer from developing.
15 Dec 2020
Roche launches cobas PIK3CA Mutation Test for patients with advanced or metastatic breast cancer in countries accepting the CE mark
27 Jan 2021
Pro-COAG is a scientific and educational event, with top experts in the area of Coagulation, sharing their knowledge on current hot topics.
Roche Diagnostics serves customers spanning the entire healthcare spectrum - from commercial laboratories, research institutions and hospitals to physicians and patients.